Arnold DL - Search Results

1

Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.

Chitnis T, Banwell B, Kappos L, Arnold DL, Gücüyener K, Deiva K, Skripchenko N, Cui LY, Saubadu S, Hu W, Benamor M, Le-Halpere A, Truffinet P, Tardieu M; TERIKIDS Investigators. Chitnis T, et al. Among authors: arnold dl. Lancet Neurol. 2021 Dec;20(12):1001-1011. doi: 10.1016/S1474-4422(21)00364-1. Lancet Neurol. 2021. PMID: 34800398 Clinical Trial.

2

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.

Matthews PM, Francis G, Antel J, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Neurology. 1991 Aug;41(8):1251-6. doi: 10.1212/wnl.41.8.1251. Neurology. 1991. PMID: 1650931

3

Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.

De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL. De Stefano N, et al. Among authors: arnold dl. Neurology. 1997 Oct;49(4):1138-41. doi: 10.1212/wnl.49.4.1138. Neurology. 1997. PMID: 9339704

4

Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study.

Li LM, Cendes F, Bastos AC, Andermann F, Dubeau F, Arnold DL. Li LM, et al. Among authors: arnold dl. Neurology. 1998 Mar;50(3):755-9. doi: 10.1212/wnl.50.3.755. Neurology. 1998. PMID: 9521269

5

Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy.

Tasch E, Cendes F, Li LM, Dubeau F, Andermann F, Arnold DL. Tasch E, et al. Among authors: arnold dl. Ann Neurol. 1999 May;45(5):568-76. doi: 10.1002/1531-8249(199905)45:5<568::aid-ana4>3.0.co;2-p. Ann Neurol. 1999. PMID: 10319878

6

Relating axonal injury to functional recovery in MS.

Reddy H, Narayanan S, Matthews PM, Hoge RD, Pike GB, Duquette P, Antel J, Arnold DL. Reddy H, et al. Among authors: arnold dl. Neurology. 2000 Jan 11;54(1):236-9. doi: 10.1212/wnl.54.1.236. Neurology. 2000. PMID: 10636158

7

Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume.

Prat A, Pelletier D, Duquette P, Arnold DL, Antel JP. Prat A, et al. Among authors: arnold dl. Ann Neurol. 2000 Feb;47(2):234-7. Ann Neurol. 2000. PMID: 10665495

8

Medial temporal lobe neuronal damage in temporal and extratemporal lesional epilepsy.

Miller SP, Li LM, Cendes F, Tasch E, Andermann F, Dubeau F, Arnold DL. Miller SP, et al. Among authors: arnold dl. Neurology. 2000 Apr 11;54(7):1465-70. doi: 10.1212/wnl.54.7.1465. Neurology. 2000. PMID: 10751259 Clinical Trial.

9

Is ictal recording mandatory in temporal lobe epilepsy? Not when the interictal electroencephalogram and hippocampal atrophy coincide.

Cendes F, Li LM, Watson C, Andermann F, Dubeau F, Arnold DL. Cendes F, et al. Among authors: arnold dl. Arch Neurol. 2000 Apr;57(4):497-500. doi: 10.1001/archneur.57.4.497. Arch Neurol. 2000. PMID: 10768623 Clinical Trial.

10

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

Narayanan S, De Stefano N, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, Pelletier D, Arnason BGW, Antel JP, Arnold DL. Narayanan S, et al. Among authors: arnold dl. J Neurol. 2001 Nov;248(11):979-86. doi: 10.1007/s004150170052. J Neurol. 2001. PMID: 11757963 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters